Treatment of Asymptomatic Bacteriuria in Pregnancy
For asymptomatic bacteriuria in pregnancy, treat with nitrofurantoin 100 mg twice daily for 4-7 days, or alternatively use cephalexin 500 mg four times daily for 4-7 days. 1, 2
Why Treatment is Essential
Pregnant women with asymptomatic bacteriuria face dramatically elevated risks that mandate treatment:
- Pyelonephritis risk increases 20-30 fold without treatment, occurring in 20-35% of untreated women versus only 1-4% with appropriate antimicrobial therapy 1, 2
- Treatment reduces preterm birth from approximately 53 per 1000 to 14 per 1000 pregnancies 2
- Very low birth weight risk decreases from 137 per 1000 to 88 per 1000 with treatment 2
- Implementation of screening programs has reduced pyelonephritis rates from 1.8-2.1% down to 0.5-0.6% 1, 3
The evidence supporting treatment is robust, based on multiple prospective randomized trials from the 1960s-1980s that consistently demonstrated these benefits, despite their age 1
Specific Antibiotic Recommendations
First-Line Options
Nitrofurantoin is the preferred agent:
- Dose: 100 mg orally twice daily for 4-7 days 2, 3
- Excellent safety profile in pregnancy 1, 2
- Effective against common uropathogens including E. coli (the most common pathogen, occurring in ~50% of cases) 4, 5
Cephalexin is the best alternative:
- Dose: 500 mg orally four times daily for 4-7 days 2, 3
- Safe throughout pregnancy with excellent blood and urinary concentrations 3
- Appropriate for penicillin-allergic patients (only 10% cross-reactivity risk) 3
Other Acceptable Options
Amoxicillin-clavulanate can be used if the pathogen is susceptible 3
Fosfomycin (single 3g dose) may be considered, though evidence is more limited 3, 6
Critical Treatment Duration
Do not use single-dose regimens - they are significantly less effective:
- A high-quality 2009 RCT of 778 pregnant women demonstrated bacteriologic cure rates of only 75.7% with 1-day nitrofurantoin versus 86.2% with 7-day treatment 4
- The cure rate difference was -10.5% (95% CI -16.1% to -4.9%), which is clinically significant 4
- Mean birth weight and gestational age were significantly lower in the 1-day treatment group 4
- The 2015 Cochrane review confirmed this trend toward lower clearance rates with single-dose therapy 1
The 4-7 day duration is based on moderate-quality evidence, with the optimal duration varying by antimicrobial agent 1. Nitrofurantoin and β-lactams require longer courses than they would for acute cystitis in non-pregnant women 1
Screening Approach
- Obtain urine culture at one of the initial prenatal visits early in pregnancy (ideally 12-16 weeks gestation) 1, 2, 3
- Asymptomatic bacteriuria occurs in 2-7% of pregnant women 1, 2
- Urine culture is the gold standard - dipstick testing is insufficient 7
Follow-Up Management
After completing treatment:
- Obtain follow-up urine culture 1-2 weeks post-treatment to confirm cure 2, 3
- Continue periodic screening with urine cultures throughout the remainder of pregnancy 2
- Recurrence is common and requires re-treatment with another 4-7 day course 2
Important Caveats
Avoid these antibiotics in pregnancy:
- Trimethoprim and trimethoprim-sulfamethoxazole in first trimester (teratogenic risk) 3
- Fluoroquinolones throughout pregnancy 3
- Tetracyclines throughout pregnancy 8
Special consideration for Group B Streptococcus:
- If GBS is isolated at any concentration, treat immediately AND provide intrapartum prophylaxis during labor 9, 3
Lactobacillus in urine culture:
- Consider this contamination or normal flora, not true bacteriuria - no treatment needed 9
The recommendation to screen and treat remains strong despite a recent Dutch study suggesting non-treatment might be acceptable in selected low-risk women, as the IDSA guideline committee concluded further evaluation in diverse populations is necessary before changing this standard of care 1